Topics

Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology

20:00 EDT 5 Jul 2017 | NIH

Due to the disorganized nature of blood vessels that run through tumors, chemotherapeutic agents often fail to penetrate tumors and kill cancer cells at the tumor’s center. This can lead to ineffective chemotherapeutic treatments, because tumors can quickly grow back if the entire tumor is not destroyed. NIH researchers have developed a therapeutic agent that solves this problem facing current chemotherapy treatments.

Original Article: Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology

NEXT ARTICLE

More From BioPortfolio on "Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...